{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:51:15Z","timestamp":1791355875352,"version":"4.3.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review utilizes the AGREE II instrument to evaluate the methodological rigor and the AGREE-REX instrument to evaluate the implementability of recommendations within clinical practice guidelines for fertility preservation in patients with breast cancer. This is the first study to comprehensively appraise related guidelines using both officially recognized instruments. The findings aim to inform clinical application by identifying high-quality and implementable guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>By June 2026, a systematic search was conducted across seven electronic databases, six guideline repositories, and relevant breast cancer society websites. Guidelines were screened according to predefined criteria, and independent quality assessments were performed using AGREE II and AGREE-REX. Inter-rater reliability was evaluated via the intraclass correlation coefficient (ICC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve guidelines were included. The AGREE II domain scores (mean standardized percentages) showed significant variations: Scope and Purpose (72.98%), Editorial Independence (71.81%), Clarity of Presentation (70.05%), Applicability (69.33%), Rigor of Development (55.30%), and Stakeholder Involvement (54.78%), highlighting critical gaps in patient participation and evidence updating mechanisms. Based on AGREE II and AGREE-REX evaluations, five guidelines were classified as Grade A (strongly recommended), four as Grade B, and three as Grade C.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The five Grade A guidelines predominantly originated from Western countries. Prior to clinical implementation, they require cultural adaptation, language translation, and local validation to align with regional healthcare systems and patient values. Future guideline development should prioritize stakeholder integration, dynamic updating mechanisms, and resource allocation assessments to enhance clinical applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , PROSPERO CRD42023464394.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1930322","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:06:43Z","timestamp":1791353203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality appraisal of clinical practice guidelines for fertility preservation in patients with breast cancer: a systematic review using AGREE II and AGREE-REX"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenjuan","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Nursing, Women and Children's Hospital, School of Medicine, Xiamen University","place":["Xiamen, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[{"name":"Digestive Endoscopy Center, Quanzhou First Hospital Affiliated to Fujian Medical University","place":["Quanzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Nursing, Li Ka Shing Faculty of Medicine, University of Hong Kong","place":["Hong Kong SAR, China"]},{"name":"Department of Nursing, Women and Children's Hospital, School of Medicine, Xiamen University","place":["Xiamen, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nursing, Women and Children's Hospital, School of Medicine, Xiamen University","place":["Xiamen, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology Center, School of Medicine, Xiamen Cardiovascular Hospital of Xiamen University, Fujian Branch of National Clinical Research Center for Cardiovascular Diseases","place":["Xiamen, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/life13051195","article-title":"The late effects of cancer treatment on female fertility and the current status of fertility preservation-A narrative review","volume":"13","author":"Rodriguez-Wallberg","year":"2023","journal-title":"Life (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-0-387-72293-1_1","article-title":"The emergence of a new inter discipline: on cofertility","volume":"138","author":"Woodruff","year":"2007","journal-title":"Cancer Treat Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7314\/apjcp.2015.16.3.1057","article-title":"Systematic review of available guidelines on fertility preservation of young patients with breast cancer","volume":"16","author":"Haddadi","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: eSMO clinical practice guidelines(\u2020)","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5653\/cerm.2017.44.4.181","article-title":"Fertility preservation for patients with breast cancer: the Korean society for fertility preservation clinical guidelines","volume":"44","author":"Kim","year":"2017","journal-title":"Clin Exp Reprod Med"},{"key":"B9","year":"2026"},{"key":"B10","doi-asserted-by":"publisher","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","year":"2020","journal-title":"Hum Reprod Open"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"Can Med Assoc J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e047980","DOI":"10.1136\/bmjopen-2020-047980","article-title":"Quality assessment and comparative analysis on the recommendations of current guidelines on the management of peripheral arterial disease: a systematic review protocol","volume":"11","author":"Uyagu","year":"2021","journal-title":"BMJ Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1007\/s00192-021-04729-7","article-title":"Treatment of urinary incontinence: a critical appraisal of clinical practice guidelines with the AGREE II instrument","volume":"32","author":"Sorrilha","year":"2021","journal-title":"Int Urogynecol J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.7507\/1672-2531.201802021","article-title":"Quality assessment of Chinese clinical practice guidelines of gastric cancer","volume":"18","author":"Xin","year":"2018","journal-title":"Chin J Evid-Based Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jclinepi.2017.12.009","article-title":"Systematic review of current guideline appraisals performed with the appraisal of guidelines for research & evaluation II instrument\u2014a third of AGREE II users apply a cut-off for guideline quality","volume":"95","author":"Hoffmann-E\u00dfer","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e205535","DOI":"10.1001\/jamanetworkopen.2020.5535","article-title":"Development and validation of a tool to assess the quality of clinical practice guideline recommendations","volume":"3","author":"Brouwers","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"B18","year":"2026"},{"key":"B19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/AOG.0b013e31824e12ce","article-title":"ACOG practice bulletin no. 126: management of gynecologic issues in women with breast cancer","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/14647273.2017.1422297","article-title":"Fertility preservation for medical reasons in girls and women: british fertility society policy and practice guideline","volume":"21","author":"Yasmin","year":"2018","journal-title":"Hum Fertil (Camb)"},{"key":"B21","year":"2026"},{"key":"B22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.7861\/clinmedicine.7-6-544","article-title":"The effects of cancer treatment on reproductive functions","volume":"7","author":"Mead","year":"2007","journal-title":"Clin Med (Lond)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.19538\/j.cjps.issn1005-2208.2025.12.09","article-title":"Clinical practice guidelines for breast cancer during pregnancy and lactation (2025 edition)","volume":"45","year":"2025","journal-title":"Chin J Pract Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.19538\/j.cjps.issn1005-2208.2025.12.12","article-title":"Clinical practice guidelines for fertility preservation in reproductive-age women with breast cancer (2025 edition)","volume":"45","year":"2025","journal-title":"Chin J Pract Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jogc.2018.05.046","article-title":"No. 366-gynaecologic management of hereditary breast and ovarian cancer","volume":"40","author":"Jacobson","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"B26","year":"2024"},{"key":"B27","doi-asserted-by":"publisher","first-page":"i1152","DOI":"10.1136\/bmj.i1152","article-title":"The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines","volume":"352","author":"Brouwers","year":"2016","journal-title":"Br Med J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e110469","DOI":"10.1371\/journal.pone.0110469","article-title":"Clinical practice guidelines and consensus statements in oncology\u2013an assessment of their methodological quality","volume":"9","author":"Jacobs","year":"2014","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1200\/JCO.19.03120","article-title":"Management of male breast cancer: aSCO guideline","volume":"38","author":"Hassett","year":"2020","journal-title":"J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0174329","DOI":"10.1371\/journal.pone.0174329","article-title":"Recommendations for patient engagement in guideline development panels: a qualitative focus group study of guideline-na\u00efve patients","volume":"12","author":"Armstrong","year":"2017","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/hex.13018","article-title":"Participation and consultation engagement strategies have complementary roles: a case study of patient and public involvement in clinical practice guideline development","volume":"23","author":"Armstrong","year":"2020","journal-title":"Health Expect"},{"key":"B32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2168479018817751","article-title":"Process management framework: guidance to successful implementation of processes in clinical development","volume":"53","author":"Husovich","year":"2019","journal-title":"Ther Innov Regul Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jclinepi.2023.08.017","article-title":"The barriers and facilitators for the implementation of clinical practice guidelines in healthcare: an umbrella review of qualitative and quantitative literature","volume":"162","author":"Zhou","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"782","DOI":"10.7326\/M23-3274","article-title":"Reporting conflicts of interest and funding in health care guidelines: the RIGHT-COI&F checklist","volume":"177","author":"Xun","year":"2024","journal-title":"Ann Intern Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines international network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1056\/NEJMp0810200","article-title":"Controlling conflict of interest\u2013proposals from the institute of medicine","volume":"360","author":"Steinbrook","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1930322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:06:47Z","timestamp":1791353207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1930322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1930322"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1930322","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1930322"}}